Comparison of Targeted vs Systematic Prostate Biopsy in Men Who Are Biopsy Naive

JAMA Surgery - Tập 154 Số 9 - Trang 811 - 2019
Fuad Elkhoury1, Ely Felker2, Lorna Kwan1, Anthony Sisk3, Merdie Delfin1, Shyam Natarajan4,1, Leonard S. Marks1
1Department of Urology, David Geffen School of Medicine, University of California, Los Angeles
2Department of Radiology, David Geffen School of Medicine, University of California, Los Angeles
3Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles
4Department of Bioengineering, University of California, Los Angeles

Tóm tắt

Từ khóa


Tài liệu tham khảo

Kasivisvanathan, 2018, MRI-targeted or standard biopsy for prostate-cancer diagnosis., N Engl J Med, 378, 1767, 10.1056/NEJMoa1801993

Ahmed, 2017, Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study., Lancet, 389, 815, 10.1016/S0140-6736(16)32401-1

Siddiqui, 2015, Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer., JAMA, 313, 390, 10.1001/jama.2014.17942

Filson, 2016, Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies., Cancer, 122, 884, 10.1002/cncr.29874

Faria, 2018, Optimising the diagnosis of prostate cancer in the era of multiparametric magnetic resonance imaging: a cost-effectiveness analysis based on the prostate MR imaging study (PROMIS)., Eur Urol, 73, 23, 10.1016/j.eururo.2017.08.018

Weinreb, 2016, PI-RADS prostate imaging—reporting and data system: 2015, version 2., Eur Urol, 69, 16, 10.1016/j.eururo.2015.08.052

Ahmed, 2009, The index lesion and the origin of prostate cancer., N Engl J Med, 361, 1704, 10.1056/NEJMcibr0905562

Epstein, 2016, A contemporary prostate cancer grading system: a validated alternative to the Gleason score., Eur Urol, 69, 428, 10.1016/j.eururo.2015.06.046

Chang, 2017, Value of tracking biopsy in men undergoing active surveillance of prostate cancer., J Urol, 0

Moore, 2013, Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group., Eur Urol, 64, 544, 10.1016/j.eururo.2013.03.030

Natarajan, 2011, Clinical application of a 3D ultrasound-guided prostate biopsy system., Urol Oncol, 29, 334, 10.1016/j.urolonc.2011.02.014

Rouvière, 2019, Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study., Lancet Oncol, 20, 100, 10.1016/S1470-2045(18)30569-2

Wysock, 2014, A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial., Eur Urol, 66, 343, 10.1016/j.eururo.2013.10.048

van der Leest, 2019, Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: a large prospective multicenter clinical study., Eur Urol, 75, 570, 10.1016/j.eururo.2018.11.023

Valerio, 2015, Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review., Eur Urol, 68, 8, 10.1016/j.eururo.2014.10.026

Mozer, 2015, First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer., BJU Int, 115, 50, 10.1111/bju.12690

Rastinehad, 2014, Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy., J Urol, 191, 1749, 10.1016/j.juro.2013.12.007

Sonn, 2013, Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device., J Urol, 189, 86, 10.1016/j.juro.2012.08.095

Le, 2015, Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology., Eur Urol, 67, 569, 10.1016/j.eururo.2014.08.079

Turkbey, 2013, Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?, Radiology, 268, 144, 10.1148/radiol.13121325

Bryant, 2019, Comparison of prostate biopsy with or without prebiopsy multiparametric magnetic resonance imaging in prostate cancer detection: an observational cohort study., J Urol, 201, 510, 10.1016/j.juro.2018.09.049

Maxeiner, 2018, Primary magnetic resonance imaging/ultrasonography fusion-guided biopsy of the prostate., BJU Int, 122, 211, 10.1111/bju.14212

Borkowetz, 2018, Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy-naïve patients., BJU Int, 121, 53, 10.1111/bju.2018.121.issue-1

Radtke, 2016, Multiparametric magnetic resonance imaging (MRI) and MRI-transrectal ultrasound fusion biopsy for index tumor detection: correlation with radical prostatectomy specimen., Eur Urol, 70, 846, 10.1016/j.eururo.2015.12.052

Rosenkrantz, 2016, Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologists., Radiology, 280, 793, 10.1148/radiol.2016152542

Mehralivand, 2018, A magnetic resonance imaging-based prediction model for prostate biopsy risk stratification., JAMA Oncol, 4, 678, 10.1001/jamaoncol.2017.5667

RosenkrantzAB, VermaS, ChoykePL, . Prostate MRI and MRI-targeted biopsy in patients with prior negative biopsy. https://www.auanet.org/guidelines/prostate-mri-and-mri-targeted-biopsy. Published 2016. Accessed May 8, 2019.